Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Liver Cancer; Early Detection; Fibrosis; Survival; AFP; α-fetoprotein; BMI; body mass index; CI; confidence interval; CT; computed tomography; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; MRI; magnet
مقالات ISI هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HALT-C cohort; Viral hepatitis; Cirrhosis; Hepatitis C; Liver cancer; adiponutrin; CI; confidence interval; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; NASH; nonalcoholic stea
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Early Detection; Hepatitis C; Cirrhosis; Surveillance; AASLD; American Association for the Study of Liver Diseases; AFP; α-fetoprotein; AUC; area under the receiver operating characteristic curve; CT; computed tomography; FPR; false-positive rate; HALT-C
Research ArticleStatin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HCV; hepatitis C virus; CHC; chronic hepatitis C; HCC; hepatocellular carcinoma; HMG CoA; 3-hydroxy-3-methylglutaryl-coenzyme A; HSCs; hepatic stellate cells; HALT-C; hepatitis C antiviral long-term treatment against cirrhosis; HAI; histology activity ind
Research ArticleStatin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; NHIRD; National Health Insurance Research Database; ICD-9 codes; International Classification of Diseases, Ninth Revision codes; DD
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Epidemiology; Viruses; Digestive System; Endocrinology; BMI; body mass index; CI; confidence interval; HALT-C; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HOMA-IR; homeostasis model a
ReviewIs there sufficient evidence to recommend antiviral therapy in hepatitis C?
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HCV; hepatitis C virus; SVR; sustained virological response; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; RCT; randomized controlled trial; OR; odds ratio; CI; confidence interval; MELD; Model for End
Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Colon Cancer; Liver Cancer; Screening; Process of Care; Effectiveness; Health Services Research; CRC; colorectal cancer; CT; computed tomography; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepa
Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Diet; Cholesterol; Hepatitis C; Cirrhosis; AHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; CTP; Child-Turcotte-Pugh; FFQ; food frequency questionnaire; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HCV; Hepatitis C virus; SNP; Single nucleotide polymorphism; PEG; Polyethylene glycol; HALT-C; Hepatitis C antiviral long-term treatment against cirrhosis; EPIC; Evaluation of PegIntron in control of hepatitis C cirrhosis; CT; Computed tomography; MR; Mag
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; HCV; Hepatitis C virus; SNP; Single nucleotide polymorphism; PEG; Polyethylene glycol; HALT-C; Hepatitis C antiviral long-term treatment against cirrhosis; EPIC; Evaluation of PegIntron in control of hepatitis C cirrhosis; CT; Computed tomography; MR; Mag
Mallory-Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Keratins; Liver Disease; Intermediate Filaments; Cytoplasmic Inclusions; BMI; body mass index; CHC; chronic hepatitis C; HALT-C; hepatitis C antiviral Long-Term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; MDBs; Mall
Research ArticleFibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; CI; confidence interval; COPILOT; Colchicine versus PegIntron Long-Term; EPIC3; Evaluation of PegIntron in Control of Hepatitis C Cirrhosis; EVR; early virologic response; FT; FibroTest; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis;
Serum Fibrosis Marker Levels Decrease After Successful Antiviral Treatment in Chronic Hepatitis C Patients With Advanced Fibrosis
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CHC; chronic hepatitis C; CI; confidence interval; HA; hyaluronic acid; HALT-C; hepatitis C antiviral long-term treatment against cirrhosis; HCV; hepatitis C virus; OR; odds ratio; PIIINP; am
Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; AFP; alpha fetoprotein; AGA; American Gastroenterological Association; ALT; alanine aminotransferase; APRI; aspartate aminotransferase platelet ratio index; AUROC; area under the receiver operator characteristics; CI; confidence interval; CT; computed tom
Blunted Cytopenias and Weight Loss: New Correlates of Virologic Null Response to Re-treatment of Chronic Hepatitis C
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; ALT; alanine aminotransferase; BMI; body mass index; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCV; hepatitis C virus; SVR; sustained virologic response; HOMA; homeostasis model assessment; ULN; upper limit of normal;
Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCV; hepatitis C virus; HOMA; homeostasis model assessment; IFN; interferon; IR; insulin resistance;
Treatment of Hepatitis C in the Patient With Decompensated Cirrhosis
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; CTP; Child-Turcotte-Pugh; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCV; hepatitis C virus; MELD; Model for End-Stage Liver Disease; SVR; sustained virologic response;
Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial
Keywords: هپاتیت C درمان طولانی مدت ضد ویروسی در برابر سیروز; Hepatitis C; Cognitive function; Neuropsychological testing; Hepatic fibrosis; BDI; beck depression inventory; BSI; brief symptom inventory; CHC; chronic hepatitis C; CIDI-LT; composite international diagnostic interview lifetime; HALT-C; hepatitis C anti